Aisner, D. L., Sholl, L. M., Berry, L. D., Rossi, M. R., Chen, H., Fujimoto, J., . . . Kwiatkowski, D. J. (2017). The Impact of Smoking and TP53 mutations in lung adenocarcinoma patients with targetable mutations – the Lung Cancer Mutation Consortium (LCMC2). Clin Cancer Res.
Παραπομπή Chicago StyleAisner, Dara L., et al. "The Impact of Smoking and TP53 Mutations in Lung Adenocarcinoma Patients With Targetable Mutations – the Lung Cancer Mutation Consortium (LCMC2)." Clin Cancer Res 2017.
Παραπομπή MLAAisner, Dara L., et al. "The Impact of Smoking and TP53 Mutations in Lung Adenocarcinoma Patients With Targetable Mutations – the Lung Cancer Mutation Consortium (LCMC2)." Clin Cancer Res 2017.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.